SNRS- Sunrise Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies

SNRS 0.000001000

0.0%

Jun 6 11:01 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bede who wrote (2520)	6/11/1999 10:01:00 AM
From: emil	Read Replies (1) of 4140

BAM! ''We will be ever vigilant to maintain the integrity of the Company's market for its stock,'' added Trenary. The Ophthalmic Devices Advisory Panel will review the Company's Premarket Approval (PMA) application on July 22, 1999 for the treatment of hyperopia (+.75 to +2.50 diopters). Sunrise believes about 31% of Americans over 40 have hyperopia from +.75 to +2.50 diopters. ''We have never been more optimistic about the Company's business, prospects and people. We believe that our new products will be enthusiastically received by patients and ophthalmologists alike,'' said Trenary.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next